Product Code: 978-1-68038-080-4
In Vitro Diagnostic Market Growth & Trends:
The global in vitro diagnostics market size is expected to reach USD 150.13 billion in 2030 and is projected to grow at a CAGR of 5.62% from 2025 to 2030. driven by the increasing geriatric population, COVID-19 pandemic, and technological advancements in diagnostics that are supporting its adoption. Technological advancements in terms of portability, accuracy, and cost-effectiveness are projected to be one of the high-impact rendering drivers. Technological advancements were further accelerated by the launch of COVID-19 IVD diagnostics and enhanced the adoption of instruments and consumables for technologies, such as PCR. Competitors in the market are increasingly adopting agreement and partnership strategies to maintain a constant flow of business for manufacturers & diagnostics for users.
These agreements are also a result of the harsh price containment strategies for government laboratories, which lowers the price in government settings. For instance, in April 2021, the Italian subsidiary of Seegene, Inc. received a USD 108.25 million tenders for public procurement for the supply of extraction reagents, as well as 7.15 million SARS-CoV-2 diagnostic tests. However, it increases the multiparty nature and complexity of the supply chain. The high prevalence of cancer and Cardiovascular Diseases (CVDs) globally is anticipated to drive diagnostic innovation to facilitate early diagnosis and meet the constantly evolving needs of consumers. Novel technologies, such as plasmonic PCR, are anticipated to commercially enter the market during the forecast period, influencing the business of existing products adversely.
In Vitro Diagnostics Market Report Highlights:
- The IVD market demonstrates a high degree of innovation, driven by advancements in molecular diagnostics, next-generation sequencing (NGS), and point-of-care testing.
- The distribution channels for in vitro diagnostics (IVD) market play a critical role in how products reach healthcare facilities, laboratories, and End Users, impacting market reach and operational efficiency
- The pricing of In vitro diagnostics (IVD) products varies significantly based on product type, complexity, and application.
- Reagents held the largest share of 65.54% of the in vitro diagnostics market in 2024, driven by significant R&D efforts from leading market players aiming to develop innovative biomarker kits
- North America dominated the in vitro diagnostics industry and accounted for a 47.43% share in 2024
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Application
- 1.2.4. Test Location
- 1.2.5. End Use
- 1.3. Regional Scope
- 1.4. Estimates and Forecast Timeline
- 1.5. Research Methodology
- 1.6. Information Procurement
- 1.6.1. Purchased Database
- 1.6.2. GVR's Internal Database
- 1.7. Details of primary research
- 1.8. Market Formulation & Validation
- 1.9. Model Details
- 1.9.1. Commodity flow analysis (Model 1)
- 1.9.1.1. Approach 1: Commodity flow approach
- 1.9.2. Volume price analysis (Model 2)
- 1.9.2.1. Approach 2: Volume price analysis
- 1.10. Research Scope and Assumptions
- 1.10.1. List of Secondary Sources
- 1.10.2. List of Primary Sources
- 1.10.3. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.3. Competitive Insights
Chapter 3. In Vitro Diagnostics Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/Ancillary Market Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Drivers Analysis
- 3.2.1.1. Introduction of Technologically Advanced Products
- 3.2.1.2. Increasing Demand for PoC Testing
- 3.2.1.3. Growing Prevalence of Target Diseases
- 3.2.1.4. Increasing External Funding for R&D
- 3.2.2. Market Restraints Analysis
- 3.2.2.1. Presence of Ambiguous Regulatory Framework
- 3.2.2.2. High Capital Investment
- 3.2.2.3. High Prices of Molecular Diagnostic Tests
- 3.2.3. Market Opportunity Analysis
- 3.2.4. Supply Chain Analysis
- 3.2.5. Distribution Channel
- 3.2.5.1. Direct Sales
- 3.2.5.2. Distributors Network
- 3.2.5.3. E-commerce and Online Platforms
- 3.2.5.4. Major Distributors
- 3.3. In Vitro Diagnostics Market Analysis Tools
- 3.3.1. Porter's Analysis
- 3.3.1.1. Bargaining power of the suppliers
- 3.3.1.2. Bargaining power of the buyers
- 3.3.1.3. Threats of substitution
- 3.3.1.4. Threats from new entrants
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Economic and Social landscape
- 3.3.2.3. Technological landscape
- 3.3.2.4. Legal landscape
- 3.4. Reimbursement Overview of IVDs and LDTs
- 3.5. Pricing Analysis
Chapter 4. In Vitro Diagnostics Market: Product Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. In Vitro Diagnostics Market: Product Movement Analysis, 2024 & 2030 (USD Billion)
- 4.3. Instruments
- 4.4. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)Reagents
- 4.4.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 4.5. Services
- 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 5. In Vitro Diagnostics Market: Technology Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. In Vitro Diagnostics Market: Technology Movement Analysis, 2024 & 2030 (USD Billion)
- 5.3. Immunoassay
- 5.3.1. Immunoassay Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.3.2. Instruments
- 5.3.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Units)
- 5.3.3. Reagents
- 5.3.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.3.4. Services
- 5.3.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.4. Hematology
- 5.4.1. Hematology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.4.2. Instruments
- 5.4.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.4.3. Reagents
- 5.4.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.4.4. Services
- 5.4.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.5. Clinical Chemistry
- 5.5.1. Clinical Chemistry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.5.2. Instruments
- 5.5.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.5.3. Reagents
- 5.5.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.5.4. Services
- 5.5.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.6. Molecular Diagnostics
- 5.6.1. Molecular Diagnostics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.6.2. Instruments
- 5.6.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.6.3. Reagents
- 5.6.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.6.4. Services
- 5.6.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.7. Coagulation
- 5.7.1. Coagulation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.7.2. Instruments
- 5.7.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.7.3. Reagents
- 5.7.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.7.4. Services
- 5.7.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.8. Microbiology
- 5.8.1. Microbiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.8.2. Instruments
- 5.8.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.8.3. Reagents
- 5.8.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.8.4. Services
- 5.8.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 5.9. Others
- 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 5.9.2. Instruments
- 5.9.2.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands)
- 5.9.3. Reagents
- 5.9.3.1. Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Reagents, Number of Tests in Million)
- 5.9.4. Services
- 5.9.4.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 6. In Vitro Diagnostics Market: Application Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. In Vitro Diagnostics Market: Application Movement Analysis, 2024 & 2030 (USD Billion)
- 6.3. Infectious Disease
- 6.3.1. Infectious Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.4. Diabetes
- 6.4.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.5. Oncology/Cancer
- 6.5.1. Oncology/Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.6. Cardiology
- 6.6.1. Cardiology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.7. Nephrology
- 6.7.1. Nephrology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.8. Autoimmune Diseases
- 6.8.1. Autoimmune Diseases Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.9. Drug Testing
- 6.9.1. Drug Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 6.10. Others
- 6.10.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 7. In Vitro Diagnostics Market: Test Location Estimates & Trend Analysis
- 7.1. Segment Dashboard
- 7.2. In Vitro Diagnostics Market: Test Location Movement Analysis, 2024 & 2030 (USD Billion)
- 7.3. Point of Care
- 7.3.1. Point of Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.4. Home-care
- 7.4.1. Home-care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 7.5. Others
- 7.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion)
Chapter 8. In Vitro Diagnostics Market: End Use Estimates & Trend Analysis
- 8.1. Segment Dashboard
- 8.2. In Vitro Diagnostics Market: End Use Movement Analysis, 2024 & 2030 (USD Billion)
- 8.3. Hospitals
- 8.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 8.4. Laboratory
- 8.4.1. Laboratory Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 8.5. Home Care
- 8.5.1. Home Care Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 8.6. Others
- 8.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
Chapter 9. In Vitro Diagnostics Market: Regional Estimates & Trend Analysis
- 9.1. In Vitro Diagnostics Market Share, By Region, 2024 & 2030, USD Billion
- 9.2. North America
- 9.2.1. North America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.2.2. U.S.
- 9.2.2.1. Key Country Dynamics
- 9.2.2.2. Regulatory Landscape/Reimbursement Scenario
- 9.2.2.3. Competitive Insights
- 9.2.2.4. U.S. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.2.3. Canada
- 9.2.3.1. Key Country Dynamics
- 9.2.3.2. Regulatory Landscape/Reimbursement Scenario
- 9.2.3.3. Competitive Insights
- 9.2.3.4. Canada In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.2.4. Mexico
- 9.2.4.1. Key Country Dynamics
- 9.2.4.2. Regulatory Landscape/Reimbursement Scenario
- 9.2.4.3. Competitive Insights
- 9.2.4.4. Mexico In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.3. Europe
- 9.3.1. Europe In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.3.2. U.K.
- 9.3.2.1. Key Country Dynamics
- 9.3.2.2. Regulatory Landscape/Reimbursement Scenario
- 9.3.2.3. Competitive Insights
- 9.3.2.4. U.K. In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.3.3. Germany
- 9.3.3.1. Key Country Dynamics
- 9.3.3.2. Regulatory Landscape/Reimbursement Scenario
- 9.3.3.3. Competitive Insights
- 9.3.3.4. Germany In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.3.4. France
- 9.3.4.1. Key Country Dynamics
- 9.3.4.2. Regulatory Landscape/Reimbursement Scenario
- 9.3.4.3. Competitive Insights
- 9.3.4.4. France In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.3.5. Italy
- 9.3.5.1. Key Country Dynamics
- 9.3.5.2. Regulatory Landscape/Reimbursement Scenario
- 9.3.5.3. Competitive Insights
- 9.3.5.4. Italy In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.3.6. Spain
- 9.3.6.1. Key Country Dynamics
- 9.3.6.2. Regulatory Landscape/Reimbursement Scenario
- 9.3.6.3. Competitive Insights
- 9.3.6.4. Spain In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.3.7. Sweden
- 9.3.7.1. Key Country Dynamics
- 9.3.7.2. Regulatory Landscape/Reimbursement Scenario
- 9.3.7.3. Competitive Insights
- 9.3.7.4. Sweden In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.3.8. Denmark
- 9.3.8.1. Key Country Dynamics
- 9.3.8.2. Regulatory Landscape/Reimbursement Scenario
- 9.3.8.3. Competitive Insights
- 9.3.8.4. Denmark In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.3.9. Norway
- 9.3.9.1. Key Country Dynamics
- 9.3.9.2. Regulatory Landscape/Reimbursement Scenario
- 9.3.9.3. Competitive Insights
- 9.3.9.4. Norway In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.4. Asia Pacific
- 9.4.1. Asia Pacific In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion)
- 9.4.2. China
- 9.4.2.1. Key Country Dynamics
- 9.4.2.2. Regulatory Landscape/Reimbursement Scenario
- 9.4.2.3. Competitive Insights
- 9.4.2.4. China In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.4.3. Japan
- 9.4.3.1. Key Country Dynamics
- 9.4.3.2. Regulatory Landscape/Reimbursement Scenario
- 9.4.3.3. Competitive Insights
- 9.4.3.4. Japan In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.4.4. India
- 9.4.4.1. Key Country Dynamics
- 9.4.4.2. Regulatory Landscape/Reimbursement Scenario
- 9.4.4.3. Competitive Insights
- 9.4.4.4. India In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.4.5. South Korea
- 9.4.5.1. Key Country Dynamics
- 9.4.5.2. Regulatory Landscape/Reimbursement Scenario
- 9.4.5.3. Competitive Insights
- 9.4.5.4. South Korea In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.4.6. Australia
- 9.4.6.1. Key Country Dynamics
- 9.4.6.2. Regulatory Landscape/Reimbursement Scenario
- 9.4.6.3. Competitive Insights
- 9.4.6.4. Australia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.4.7. Thailand
- 9.4.7.1. Key Country Dynamics
- 9.4.7.2. Regulatory Landscape/Reimbursement Scenario
- 9.4.7.3. Competitive Insights
- 9.4.7.4. Thailand In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.5. Latin America
- 9.5.1. Latin America In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.5.2. Brazil
- 9.5.2.1. Key Country Dynamics
- 9.5.2.2. Regulatory Landscape/Reimbursement Scenario
- 9.5.2.3. Competitive Insights
- 9.5.2.4. Brazil In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.5.3. Argentina
- 9.5.3.1. Key Country Dynamics
- 9.5.3.2. Regulatory Landscape/Reimbursement Scenario
- 9.5.3.3. Competitive Insights
- 9.5.3.4. Argentina In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.6. Middle East and Africa
- 9.6.1. Middle East and Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.6.2. Saudi Arabia
- 9.6.2.1. Key Country Dynamics
- 9.6.2.2. Regulatory Landscape/Reimbursement Scenario
- 9.6.2.3. Competitive Insights
- 9.6.2.4. Saudi Arabia In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.6.3. UAE
- 9.6.3.1. Key Country Dynamics
- 9.6.3.2. Regulatory Landscape/Reimbursement Scenario
- 9.6.3.3. Competitive Insights
- 9.6.3.4. UAE In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.6.4. South Africa
- 9.6.4.1. Key Country Dynamics
- 9.6.4.2. Regulatory Landscape/Reimbursement Scenario
- 9.6.4.3. Competitive Insights
- 9.6.4.4. South Africa In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
- 9.6.5. Kuwait
- 9.6.5.1. Key Country Dynamics
- 9.6.5.2. Regulatory Landscape/Reimbursement Scenario
- 9.6.5.3. Competitive Insights
- 9.6.5.4. Kuwait In Vitro Diagnostics Market Estimates and Forecasts, 2018 - 2030 (USD Billion) (Volume, Number of Instruments, in Thousands) (Volume, Reagents, Number of Tests in Million)
Chapter 10. Competitive Landscape
- 10.1. Recent Developments & Impact Analysis by Key Market Participants
- 10.2. Company Categorization
- 10.3. Global Company Market Share Analysis, 2024
- 10.4. Company Heat Map Analysis
- 10.5. Strategy Mapping
- 10.5.1. Expansion
- 10.5.2. Mergers & Acquisition
- 10.5.3. Partnerships & Collaborations
- 10.5.4. New Product Launches
- 10.5.5. Research And Development
- 10.6. Company Profiles
- 10.6.1. Abbott
- 10.6.1.1. Participant's Overview
- 10.6.1.2. Financial Performance
- 10.6.1.3. Product Benchmarking
- 10.6.1.4. Recent Developments
- 10.6.2. Bio-Rad Laboratories, Inc
- 10.6.2.1. Participant's Overview
- 10.6.2.2. Financial Performance
- 10.6.2.3. Product Benchmarking
- 10.6.2.4. Recent Developments
- 10.6.3. Siemens Healthineers AG
- 10.6.3.1. Participant's Overview
- 10.6.3.2. Financial Performance
- 10.6.3.3. Product Benchmarking
- 10.6.3.4. Recent Developments
- 10.6.4. BIOMERIEUX
- 10.6.4.1. Participant's Overview
- 10.6.4.2. Financial Performance
- 10.6.4.3. Product Benchmarking
- 10.6.4.4. Recent Developments
- 10.6.5. BD
- 10.6.5.1. Participant's Overview
- 10.6.5.2. Financial Performance
- 10.6.5.3. Product Benchmarking
- 10.6.5.4. Recent Developments
- 10.6.6. QIAGEN
- 10.6.6.1. Participant's Overview
- 10.6.6.2. Financial Performance
- 10.6.6.3. Product Benchmarking
- 10.6.6.4. Recent Developments
- 10.6.7. Quidel Corporation
- 10.6.7.1. Participant's Overview
- 10.6.7.2. Financial Performance
- 10.6.7.3. Product Benchmarking
- 10.6.7.4. Recent Developments
- 10.6.8. F. Hoffmann-La Roche Ltd.
- 10.6.8.1. Participant's Overview
- 10.6.8.2. Financial Performance
- 10.6.8.3. Product Benchmarking
- 10.6.8.4. Recent Developments
- 10.6.9. Danaher
- 10.6.9.1. Participant's Overview
- 10.6.9.2. Financial Performance
- 10.6.9.3. Product Benchmarking
- 10.6.9.4. Recent Developments
- 10.6.10. Quest Diagnostics Incorporated
- 10.6.10.1. Participant's Overview
- 10.6.10.2. Financial Performance
- 10.6.10.3. Product Benchmarking
- 10.6.10.4. Recent Developments
- 10.6.11. Agilent Technologies, Inc.
- 10.6.11.1. Participant's Overview
- 10.6.11.2. Financial Performance
- 10.6.11.3. Product Benchmarking
- 10.6.11.4. Recent Developments